{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:32:27Z","timestamp":1787563947237,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22075324"],"award-info":[{"award-number":["22075324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51820105004"],"award-info":[{"award-number":["51820105004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2304201"],"award-info":[{"award-number":["2022YFC2304201"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.actbio.2022.12.042","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:07:19Z","timestamp":1671826039000},"page":"525-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections"],"prefix":"10.1016","volume":"158","author":[{"given":"Haolin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.actbio.2022.12.042_bib0001","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Le","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.actbio.2022.12.042_bib0002","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/infdis\/jix482","article-title":"Immunogenicity and safety of the HZ\/su adjuvanted herpes zoster subunit vaccine in adults previously vaccinated with a live attenuated herpes zoster vaccine","volume":"216","author":"Grupping","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.actbio.2022.12.042_bib0003","doi-asserted-by":"crossref","first-page":"10621","DOI":"10.1021\/acsnano.8b05950","article-title":"Nanoparticles for immune stimulation against infection, cancer, and autoimmunity","volume":"12","author":"Singha","year":"2018","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.actbio.2022.12.042_bib0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","article-title":"Current applications of nanoparticles in infectious diseases","volume":"224","author":"Zazo","year":"2016","journal-title":"J. Controll. Release"},{"issue":"24","key":"10.1016\/j.actbio.2022.12.042_bib0005","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0006","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/vaccines8010128","article-title":"Better adjuvants for better vaccines: Progress in adjuvant delivery systems, modifications, and adjuvant\u2013antigen codelivery","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.03.020","article-title":"Advancements in prophylactic and therapeutic nanovaccines","volume":"108","author":"Bhardwaj","year":"2020","journal-title":"Acta Biomater."},{"issue":"17","key":"10.1016\/j.actbio.2022.12.042_bib0008","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0009","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.actbio.2022.12.042_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0011","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jconrel.2022.10.053","article-title":"Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels","volume":"352","author":"Liu","year":"2022","journal-title":"J. Controll. Release"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0012","doi-asserted-by":"crossref","first-page":"113966","DOI":"10.1016\/j.addr.2021.113966","article-title":"Immunological perspectives on spatial and temporal vaccine delivery","volume":"178","author":"Zhu","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"19","key":"10.1016\/j.actbio.2022.12.042_bib0013","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1039\/C8NR01376D","article-title":"Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity","volume":"10","author":"An","year":"2018","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0014","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11431-021-2011-7","article-title":"Fabrication of subunit nanovaccines by physical interaction","volume":"65","author":"Chen","year":"2022","journal-title":"Sci. China"},{"issue":"6","key":"10.1016\/j.actbio.2022.12.042_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/vaccines9060563","article-title":"Chemical conjugation strategies for the development of protein-based subunit nanovaccines","volume":"9","author":"Lu","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.actbio.2022.12.042_bib0016","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1021\/acs.nanolett.8b00478","article-title":"Potency of a scalable nanoparticulate subunit vaccine","volume":"18","author":"Qiao","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2022.12.042_bib0017","doi-asserted-by":"crossref","first-page":"113927","DOI":"10.1016\/j.addr.2021.113927","article-title":"Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors","volume":"177","author":"Ye","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2022.12.042_bib0018","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/vaccines3030662","article-title":"Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy","volume":"3","author":"Fan","year":"2015","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.08.009","article-title":"Lymph node targeting strategies to improve vaccination efficacy","volume":"267","author":"Jiang","year":"2017","journal-title":"J. Controll. Release"},{"issue":"11","key":"10.1016\/j.actbio.2022.12.042_bib0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour\u2014targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"31","key":"10.1016\/j.actbio.2022.12.042_bib0021","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1039\/C9TB00448C","article-title":"A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization","volume":"7","author":"Wu","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0022","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.biomaterials.2016.10.016","article-title":"Drug self-delivery systems for cancer therapy","volume":"112","author":"Qin","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.actbio.2022.12.042_bib0024","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.actbio.2022.01.004","article-title":"Antigen epitope-TLR7\/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy","volume":"141","author":"Song","year":"2022","journal-title":"Acta Biomater."},{"issue":"13","key":"10.1016\/j.actbio.2022.12.042_bib0026","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.addr.2012.08.005","article-title":"Interactions of nanomaterials and biological systems: implications to personalized nanomedicine","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"9","key":"10.1016\/j.actbio.2022.12.042_bib0027","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1021\/acs.nanolett.1c00648","article-title":"Enhanced antitumor immune responses via a self-assembled carrier-free nanovaccine","volume":"21","author":"Liu","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0028","doi-asserted-by":"crossref","first-page":"100919","DOI":"10.1016\/j.pmatsci.2021.100919","article-title":"Carrier-free nanomedicines for cancer treatment","volume":"125","author":"Liu","year":"2022","journal-title":"Prog. Mater Sci."},{"issue":"24","key":"10.1016\/j.actbio.2022.12.042_bib0029","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.2217\/nnm-2018-0288","article-title":"The \u03c0\u2013\u03c0 stacking-guided supramolecular self-assembly of nanomedicine for effective delivery of antineoplastic therapies","volume":"13","author":"Yang","year":"2018","journal-title":"Nanomedicine"},{"issue":"37","key":"10.1016\/j.actbio.2022.12.042_bib0030","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1002\/anie.201703744","article-title":"Substituent effects in parallel-displaced \u03c0\u2013\u03c0 stacking interactions: distance matters","volume":"56","author":"Riwar","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"issue":"6","key":"10.1016\/j.actbio.2022.12.042_bib0031","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acs.jcim.1c00235","article-title":"3D interaction homology: hydropathic analyses of the \u201c\u03c0\u2013cation\u201d and \u201c\u03c0\u2013\u03c0\u201d interaction motifs in phenylalanine, tyrosine, and tryptophan residues","volume":"61","author":"Al Mughram","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"43","key":"10.1016\/j.actbio.2022.12.042_bib0032","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1021\/jacs.8b09223","article-title":"Diprovocims: a new and exceptionally potent class of toll-like receptor agonists","volume":"140","author":"Morin","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"37","key":"10.1016\/j.actbio.2022.12.042_bib0033","doi-asserted-by":"crossref","first-page":"E8698","DOI":"10.1073\/pnas.1809232115","article-title":"Adjuvant effect of the novel TLR1\/TLR2 agonist Diprovocim synergizes with anti\u2013PD-L1 to eliminate melanoma in mice","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0034","doi-asserted-by":"crossref","first-page":"120158","DOI":"10.1016\/j.biomaterials.2020.120158","article-title":"Therapeutic nanovaccines sensitize EBV-associated tumors to checkpoint blockade therapy","volume":"255","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2022.03.006","article-title":"Self-degradable poly (\u03b2-amino ester) s promote endosomal escape of antigen and agonist","volume":"345","author":"Liu","year":"2022","journal-title":"J. Controll. Release"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0036","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2017.03.033","article-title":"Synthetic nanovaccines for immunotherapy","volume":"263","author":"Luo","year":"2017","journal-title":"J. Controll. Release"},{"issue":"6","key":"10.1016\/j.actbio.2022.12.042_bib0037","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s12274-020-2737-5","article-title":"Reverse immune suppressive microenvironment in tumor draining lymph nodes to enhance anti-PD1 immunotherapy via nanovaccine complexed microneedle","volume":"13","author":"Zhou","year":"2020","journal-title":"Nano Res."},{"issue":"10","key":"10.1016\/j.actbio.2022.12.042_bib0038","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1002\/jcp.28358","article-title":"PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14572","article-title":"Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice","volume":"8","author":"Lau","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0040","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0041","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/btm2.10005","article-title":"Engineering nanoparticles to overcome barriers to immunotherapy","volume":"1","author":"Toy","year":"2016","journal-title":"Bioeng. Transl. Med."},{"issue":"11","key":"10.1016\/j.actbio.2022.12.042_bib0042","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14760584.2020.1858058","article-title":"Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges","volume":"19","author":"Ahmad","year":"2020","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0043","doi-asserted-by":"crossref","first-page":"101031","DOI":"10.1016\/j.nantod.2020.101031","article-title":"Nanotechnology for virus treatment","volume":"36","author":"Zhou","year":"2021","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.actbio.2022.12.042_bib0044","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.vaccine.2010.11.061","article-title":"Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination","volume":"29","author":"Bal","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.actbio.2022.12.042_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.028","article-title":"Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy","volume":"85","author":"Huang","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.12.042_bib0046","doi-asserted-by":"crossref","first-page":"120674","DOI":"10.1016\/j.biomaterials.2021.120674","article-title":"Engineered therapeutic nanovaccine against chronic hepatitis B virus infection","volume":"269","author":"Qiao","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.actbio.2022.12.042_bib0047","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2013.03.010","article-title":"Immune system targeting by biodegradable nanoparticles for cancer vaccines","volume":"168","author":"Silva","year":"2013","journal-title":"J. Controll. Release"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122008522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:06:02Z","timestamp":1761674762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122008522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":47,"alternative-id":["S1742706122008522"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.042","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}